Home › Research › Disparities
Global Burden of Alzheimer's disease and other dementias in adults aged 65 years and older, 1991–2021: population-based study
Zhu Xiaopeng, Jing Yu, Lai Xia, Xingsheng Wang, Deng Juan, Yan Nian long, Li Baoshan. Frontiers in Public Health, 2025-07-01
Topic: Risk, prevention and care in population studies
Plain-language summary
The global mortality of ADRD among adults aged ≥65 years increased by 115%, from 6.5 (95% UI 1.5-18) per 100,000 population in 1991 to 14 (95% UI 3.5-37) per 100,000 population in 2021, with an Average Annual Percentage Change (AAPC) of 1.10% (95%CI 0.45%-1.76%). The prevalence of ADRD in adults aged ≥65 years increased by 160% between 1991 and 2021, from 18.7 (95%UI 14.9-23.2) million to 49 (95%UI 38.6-61.2) million. The aged ≥65 years age-standardized prevalence of ADRD in this age group increased from 11,977 (95%UI 9,438-14,935) per 100,000 population in 1991 to 12,124 (95%UI 9,489-15,204) per 100,000 population in 2021. The aged ≥65 years the number of prevalent persons was more significant among females than among males (males: from 6.2 (95%UI 4.8-7.8) million in 1991 to 17.2 (95%UI 13.4-21.6) million in 2021; women: from 12.5 (95%UI 10.0-15.4) million in 1991 to 31.7 (95%UI 25.1-39.6) million in 2021). In 2021, ADRD in adults aged ≥65 years caused 8.02 (95%UI 1.34-22.19) million deaths and 25.38 (95%UI 23.18-71.20) million DALYs attributable to dementia, and high BMI, high fasting glucose, and smoking remained modifiable risk factors in all risk factors. From 1991 to 2021, the worldwide prevalence of Alzheimer's disease and other dementias among adults aged 65 and above has increased by 1.6 times, largely driven by the expanding older adults. This escalating trend poses significant challenges to the global healthcare system in terms of both mortality rates and disability-adjusted life years. We recommend that standardized screening programmes be promoted globally, especially in high-risk areas and among high-risk populations, for early detection and intervention of the disease. Secondly, we recommend strengthening the management of risk factor elements.
What this study adds
Evidence grade: High
This is a pooled review. This population-based study reports that global deaths and prevalence of Alzheimer's disease and other dementias among adults aged 65 and older rose substantially between 1991 and 2021, with high BMI, high fasting glucose, and smoking remaining modifiable risk factors. Reported effect size: increased by 115%; 1.10%; 0.45%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Xiaopeng, Z., Yu, J., Xia, L., Wang, X., Juan, D., long, Y. N., et al. (2025). Global Burden of Alzheimer's disease and other dementias in adults aged 65 years and older, 1991–2021: population-based study. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2025.1585711
Vancouver
Xiaopeng Z, Yu J, Xia L, Wang X, Juan D, long YN, et al. Global Burden of Alzheimer's disease and other dementias in adults aged 65 years and older, 1991–2021: population-based study. Frontiers in Public Health. 2025. doi:10.3389/fpubh.2025.1585711. PMID: 40666154.
BibTeX
@article{xiaopeng2025-40666154,
author = {Xiaopeng, Zhu and Yu, Jing and Xia, Lai and Wang, Xingsheng and Juan, Deng and long, Yan Nian and Baoshan, Li},
title = {{Global Burden of Alzheimer's disease and other dementias in adults aged 65 years and older, 1991–2021: population-based study}},
journal = {Frontiers in Public Health},
year = {2025},
doi = {10.3389/fpubh.2025.1585711},
pmid = {40666154},
url = {https://doi.org/10.3389/fpubh.2025.1585711}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- The global mortality of ADRD among adults aged ≥65 years increased by 115%, from 6.5 (95% UI 1.5-18) per 100,000 population in 1991 to 14 (95% UI 3.5-37) per 100,000 population in 2021, with an Average Annual Percentage Change (AAPC) of 1.10% (95%CI 0.45%-1.76%).
- The prevalence of ADRD in adults aged ≥65 years increased by 160% between 1991 and 2021, from 18.7 (95%UI 14.9-23.2) million to 49 (95%UI 38.6-61.2) million.
- The aged ≥65 years age-standardized prevalence of ADRD in this age group increased from 11,977 (95%UI 9,438-14,935) per 100,000 population in 1991 to 12,124 (95%UI 9,489-15,204) per 100,000 population in 2021.
- The aged ≥65 years the number of prevalent persons was more significant among females than among males (males: from 6.2 (95%UI 4.8-7.8) million in 1991 to 17.2 (95%UI 13.4-21.6) million in 2021; women: from 12.5 (95%UI 10.0-15.4) million in 1991 to 31.7 (95%UI 25.1-39.6) million in 2021).
- In 2021, ADRD in adults aged ≥65 years caused 8.02 (95%UI 1.34-22.19) million deaths and 25.38 (95%UI 23.18-71.20) million DALYs attributable to dementia, and high BMI, high fasting glucose, and smoking remained modifiable risk factors in all risk factors.
Why it matters
This population-based study reports that global deaths and prevalence of Alzheimer's disease and other dementias among adults aged 65 and older rose substantially between 1991 and 2021, with high BMI, high fasting glucose, and smoking remaining modifiable risk factors. It describes the growing burden and risk factors, not a treatment or cure.
New to this subject? Start with our plain-English guide: Disparities →
Study details
- Study designsystematic review
- Effect sizeincreased by 115%; 1.10%; 0.45%
- Evidence strengthHigh
How this study scored 68/100
Published in a peer-reviewed journal, and it is a systematic review of all the studies on the question. Scored zero for sample size and studied in people because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 65 of the 96 points we could judge it on, which is 68 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Frontiers in Public Health) |
| Journal's citation record | 2 / 4 | Frontiers in Public Health: journal h-index 174 (OpenAlex, 2026-10-29) |
| Study design | 12 / 12 | A systematic review of all the studies on the question |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | 4 / 7 | Cited 89 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 29.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 6 / 6 | Cited 56.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 2 other studies in this library |
| Still being cited | 3 / 4 | Cited 89 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | 0 / 3 | Chongqing University: institution h-index 493 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40666154) |
| Free to read | 2 / 2 | Free to read |
| Points | 65 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 65 of the 96 points we could judge it on is 68 out of 100. |
| Total | 68 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3389/fpubh.2025.1585711
- PubMed: 40666154
- Original source →
- Free full text: Frontiers in Public Health →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
2 studies in the alzhub library list this one in their references.
Related studies in Disparities from nearby years
Also tagged “prevalence”
1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.